Chaoying Cheng

Title: Chaoying Cheng: Pharmaceutical Patent Inventor

Introduction

Chaoying Cheng is an inventor associated with Taizhou, China, whose patent work focuses on pharmaceutical compounds and their potential medical applications. His listed professional affiliations include Shanghai Aryl Pharmtech Co., Ltd. and Zhejiang Hisun Pharmaceutical Co., Ltd. Cheng is credited with 2 patents.

Latest Patents

Cheng’s listed patents concern compounds investigated as potential therapeutic agents:

- Tetracyclic Derivative, Method for Preparing Same and Use Thereof in Medicine. This patent describes a tetracyclic derivative, methods for preparing it, and pharmaceutically acceptable salts. It identifies the compounds’ potential use as therapeutic agents, particularly as K-Ras GTPase inhibitors.

- Quinazoline Derivative, or Preparation Method Therefor and Use Thereof. This patent covers substituted quinazoline derivatives, methods of preparation, and pharmaceutical compositions containing them. It describes their potential medical use, particularly as SOS1 inhibitors.

Career Highlights

Cheng’s patent portfolio reflects research into targeted therapeutic compounds, including candidates directed at K-Ras GTPase and SOS1. His listed company affiliations connect his work with pharmaceutical organizations in China.

Collaborations

Cheng’s listed coworker is Cheng Ye. The available information does not specify the nature or scope of their collaboration.

Conclusion

Chaoying Cheng’s two listed patents focus on pharmaceutical derivatives and their potential roles as targeted therapeutic agents, highlighting his contributions to medicinal innovation.